TIMING OF PCI IN PATIENTS UNDERGOING TRANSCATHETER AORTIC-VALVE IMPLANTATION

B.E. Stähli, F. Ruschitzka, D. Westermann, A. Linke, N. Mangner, N.M. Van Mieghem, R. Kesterke, L. Oberholzer, J. Rothe, C. von zur Mühlen, T. Zeus, W.-K. Kim, P. Lauten, N. Werner, C. Burgdorf, H. Alber, P.C. Schulze, M. Joner, J. Michel, A. Candreva,

The study presents findings from an international, open-label, randomized, noninferiority trial conducted at 48 centers in Europe. It compares two strategies: TAVI before PCI and PCI before TAVI, in patients with severe aortic stenosis and coronary artery disease. The primary endpoint was a composite of death from any cause, nonfatal myocardial infarction, and ischemia-driven revascularization, among other secondary endpoints. The results aim to clarify the best approach for managing these patients to improve outcomes.